THC BioMed Announces Shipment of Kiss Mango Beverage Shot to Ontario Cannabis Stores
THC BioMed Intl Ltd. has successfully shipped its THC Kiss Mango Beverage shot to Ontario Cannabis Stores. This milestone reflects the company's commitment to becoming a leader in the cannabis beverage and edible market. Established in 2013, THC BioMed is one of Canada's oldest licensed cannabis producers and is focused on scientific research and product development in this growing industry. The company holds licenses for various cannabis products and aims to leverage its extensive experience to enhance its market position.
- Successful shipment of THC Kiss Mango Beverage shot reflects operational progress.
- Positioning as a leader in the cannabis beverage and edible sector.
- None.
THC.CSE
THCBF - OTC
TFHD.F
VANCOUVER, BC, Aug. 17, 2021 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed" or the "Company") is pleased to announce that it has completed a shipment of its THC Kiss Mango Beverage shot to Ontario Cannabis Stores.
About THC
THC BioMed is one of Canada's oldest active licensed cannabis companies. It was first licensed to deal with cannabis in 2013 under a Health Canada Section 56 exemption under the Controlled Drugs and Substances Act and has been a Licensed Producer under the current regime since 2016. It aims to be a leader in the beverage and edible space.
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is on the leading edge of scientific research and the development of products and services in the medical and recreational cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements using words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this release are made as of the date of this press release and include that THC BioMed will be on the forefront of this rapidly growing industry. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thc-biomed-announces-shipment-of-kiss-mango-beverage-shot-to-ontario-cannabis-stores-301356351.html
SOURCE THC BioMed
FAQ
What is THC BioMed's recent announcement regarding THCBF?
When did THC BioMed announce the shipment of its beverage shot?
What is the significance of the THC Kiss Mango Beverage shipment for THCBF?
How long has THC BioMed been in operation?
What types of products does THC BioMed produce?
